APS James McKeen Cattell Fellow Award Address (2017; 49 min)
Robert DeRubeis is internationally known for his innovative and influential psychotherapy treatment outcomes research. His work identifying the underlying causal mechanisms of psychotherapy as well as the methodological sophistication of his research has established beyond doubt the efficacy of psychological treatments for depression and has clarified what works for whom and why.
Dr. DeRubeis discusses his surprising and somewhat controversial findings on how a study that looked at how antidepressant medication affects people with varying degrees of depression. Millions of people suffer from depression, and subsequently are treated with antidepressant medications. Cognitive-behavioral therapy (CBT) also appears to be a good treatment option for people struggling with depression, but the effectiveness of the treatment has been subjected to less empirical testing. Hear Dr. DeRubeis answer essential questions such as “what gets people better faster?” and “what keeps depression at bay over the long term?”
“Medication of Sadness” (2013; 52 min)
Recent decades have seen progressively more inclusive definitions of depression in psychiatry, with less severe mood-related problems being classified as depression and correspondingly more patients treated with antidepressant medications. In this lecture, Dr. DeRubeis analyzes these trends and some of the factors that contribute to them, including drug companies, the FDA, healthcare finance and awareness regarding nonmedical therapies.